Related Experiment Video
Updated: Apr 28, 2026
11:43
A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans
Published on: October 16, 2015
12.5K
A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans.
Pénélope A Andreux1, Laurent Mouchiroud2, Xu Wang2
11] Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland [2].
Scientific Reports
|June 14, 2014
Summary
Researchers developed a novel assay platform to screen drugs for mitochondrial effects in cells and C. elegans. This approach identified compounds impacting mitochondrial function and provided new mechanistic insights across species.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Mitochondria are crucial organelles regulating cellular homeostasis.
- Identifying mitochondrial modulators is challenging due to complex cellular impacts.
- Assessing multiple parameters in parallel is necessary to understand drug effects.
Purpose of the Study:
- To develop and validate a high-throughput screening platform for mitochondrial function.
- To identify FDA-approved drugs affecting mitochondrial activity in mammalian cells and C. elegans.
- To elucidate the mechanisms of action for specific drug classes on mitochondrial respiration.
Main Methods:
- Established a platform of assays to measure mitochondrial function in mammalian cells and C. elegans.
- Optimized cell culture and screened 1,200 FDA-approved drugs in liver cells.
- Defined metabolic effects of imidazoles and statins using cell-based and C. elegans assays.
Main Results:
- Successfully screened 1,200 FDA-approved drugs for mitochondrial effects.
- Identified imidazoles and statins as drug classes affecting respiration via distinct, cholesterol-independent mechanisms.
- Validated compounds with toxic or beneficial effects on mitochondrial activity.
- Cross-species approach provided novel mechanistic insights and early hit validation.
Conclusions:
- The developed screening platform effectively identifies mitochondrial modulators.
- Imidazoles and statins impact mitochondrial respiration through unique pathways.
- A cross-species approach accelerates the validation and mechanistic understanding of mitochondrial drugs.
